No application received for covishield authorisation, says EMA.

The European Medicines Agency (EMA) has not received any application from the Serum institute of India for authorisation of Covishield, a COVID-19 vaccine, almost a fortnight after the EU introduced the EU Digital Covid Certificate that makes intra-EU travel possible. 

“For the COVID-19 vaccine Covishield to be evaluated for use in the EU, the developer needs to submit a formal marketing authorisation application to EMA, which to date has not been received,” the EMA said at a press meeting. 

Covishield vaccine, manufactured under technology transfer from Oxford/AstraZeneca, is not among the authorised vaccines under the EMA.   

Covishield has also been excluded despite holding an EUL , this means people with Covishield will be subject to quarantine protocol in several countries.